Cosmos Days Sales Outstanding from 2010 to 2025

COSM Stock  USD 0.36  0.12  24.79%   
Cosmos Health Days Sales Outstanding yearly trend continues to be very stable with very little volatility. Days Sales Outstanding is likely to drop to 82.94. During the period from 2010 to 2025, Cosmos Health Days Sales Outstanding quarterly data regression pattern had sample variance of  2,674 and median of  66.01. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
121.61
Current Value
82.94
Quarterly Volatility
51.71092663
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cosmos Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cosmos Health's main balance sheet or income statement drivers, such as Interest Expense of 1.6 M, Selling General Administrative of 25.6 M or Other Operating Expenses of 90.8 M, as well as many indicators such as Price To Sales Ratio of 0.27, Dividend Yield of 2.83 or PTB Ratio of 0.57. Cosmos financial statements analysis is a perfect complement when working with Cosmos Health Valuation or Volatility modules.
  
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.

Latest Cosmos Health's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Cosmos Health over the last few years. It is Cosmos Health's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cosmos Health's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Cosmos Days Sales Outstanding Regression Statistics

Arithmetic Mean91.74
Geometric Mean78.29
Coefficient Of Variation56.37
Mean Deviation41.99
Median66.01
Standard Deviation51.71
Sample Variance2,674
Range178
R-Value0.58
Mean Square Error1,917
R-Squared0.33
Significance0.02
Slope6.25
Total Sum of Squares40,110

Cosmos Days Sales Outstanding History

2025 82.94
2024 121.61
2023 135.12
2022 165.02
2021 195.59
2020 177.27
2019 85.26

About Cosmos Health Financial Statements

Cosmos Health investors utilize fundamental indicators, such as Days Sales Outstanding, to predict how Cosmos Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 121.61  82.94 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Cosmos Health is a strong investment it is important to analyze Cosmos Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cosmos Health's future performance. For an informed investment choice regarding Cosmos Stock, refer to the following important reports:
Check out the analysis of Cosmos Health Correlation against competitors.
To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.45)
Revenue Per Share
3.345
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.19)
Return On Equity
(0.51)
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.